Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
Key Highlights
- ➤Starling Oncology (STLN) leadership recaps recent industry conference participation.
- ➤Dr. Podnos joins two AVBCC Summit panels October 8, 2026.
- ➤Dr. Podnos presents behavioral health model at APG Fall Conference November 19.
- ➤Starling Nexus platform addresses oncology utilization management and care coordination.
Expert Statements
Yale D. Podnos, Chief Medical Officer and President of Practice of Starling Oncology
“Value-based oncology gives us the opportunity to align clinical innovation with better outcomes for patients. At Starling Oncology, our community-based model allows us to expand access to novel therapies and clinical trials while using evidence-based pathways to deliver high-quality, coordinated cancer care closer to where patients live.”
Jeffrey Langsam, Chief Clinical Officer of Starling Oncology
“Community-based oncology practices remain the backbone of cancer care delivery in the United States. Yet practices operating within the traditional fee-for-service structure face increasing pressure from rising drug costs, IRA-related changes and biosimilar adoption. Starling Oncology’s coordinated care model and the recently launched Starling Nexus significantly reduce exposure to these pressures by realigning financial incentives for providers all while maintaining consistent levels of excellence in care.”
CERRITOS, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today highlighted its leadership team’s active season of industry engagement, recapping recent conference participation and previewing upcoming appearances at major industry events.
These presentations reflect Starling Oncology’s role in advancing the science and practice of value-based community oncology. Across these forums, the Company’s physician leaders are sharing clinical insights drawn from its proprietary and innovative Starling Nexus™ utilization management platform and its community-based care model, including approaches to delivering novel therapies at scale, expanding clinical trial access, and integrating behavioral health into cancer care.
Get started
Create a free account to read the full story.